ClinicalTrials.gov
public full text
Public Domain
Effect of CPAP on Biomarkers in Patients With OSA
CPAP, the standard treatment for Obstructive sleep apnea syndrome (OSAS) that reduces sleep fragmentations and neurocognitive deficit in OSAS may also have a key role in reduction of cardiovascular, mortality risks in the same patients.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Heart Biomarker Evaluation in Apnea Treatment#910080
- Continuous Positive Airway Pressure on Acute Stroke and Obstructive Sleep Apnea#1103165
- Obstructive Sleep Apnea (OSA) in Pulmonary Arterial Hypertension (PAH)#890714
- Systemic Inflammation and Obstructive Sleep Apnea Syndrome: Effect of Atorvastatin#857586
- The Brain Changes in Sleep Apnea Study#1059549
Record · ID 866746
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive